drugset / Trial / NCT02955654

Acceptance and Commitment Therapy in SSRI-Resistant Obsessive Compulsive Disorder

NCT02955654

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether acceptance and commitment therapy is effective in the treatment of SSRIs-resistant obsessive- compulsive disorder.

Timeline

Start
2017-09-01
Primary completion
2018-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aripiprazole Other / unclassified 10 mg
Comparator Aripiprazole Other / unclassified 20 mg